Docetaxel Clinic Trials
 
- Most are recruiting patients, click on the title to see the contact details -
Docetaxel Full Information / Docetaxel Clinical Trials / Docetaxel Patents / Price / Order / Contact us /

Total 101 Docetaxel Clinical Trials 
                         (Data from NIH, USA)

No. 1 - 50 Clkinical Trials / 51 - 101 Clinical trials /

No. 51 - 101 Clinical trials:

51. Recruiting Ketoconazole Plus Docetaxel to Treat Prostate Cancer
Condition: Prostatic Neoplasms
52. Recruiting P-glycoprotein Antagonist, Tariquidar, in Combination with Doxorubicin (Adriamycin), Vinorelbine (Navelbine), or Docetaxel to Treat Children with Solid Tumors
Conditions: Brain Tumor; Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma
53. Recruiting Primary Chemotherapy with Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer
Conditions: Breast Cancer; Breast Neoplasm
54. Recruiting Docetaxel and Flavopiridol to Treat Breast Cancer
Condition: Breast Cancer
55. Recruiting Phase 2 Study of VELCADE Alone or VELCADE plus Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
Condition: Non-small cell lung cancer
56. Recruiting Phase I Trial of Fixed Dose STI571 (Imanitib Mesylate) with Escalating Doses of Docetaxel in Patients with Metastatic Androgen-Independent Prostate Cancer
Condition: Prostate Cancer
57. Recruiting Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
58. Recruiting R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy
Conditions: stage IV breast cancer; recurrent breast cancer
59. Recruiting Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: recurrent metastatic squamous neck cancer with occult primary; metastatic squamous neck cancer with occult primary squamous cell carcinoma; ...
60. Recruiting Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
61. Recruiting Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage I prostate cancer
62. Recruiting Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer and Positive Axillary Lymph Nodes
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
63. Recruiting Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
Conditions: stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer
64. Recruiting Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus
Conditions: stage II esophageal cancer; stage III esophageal cancer; squamous cell carcinoma of the esophagus; Adenocarcinoma of the Esophagus
65. Recruiting Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
Conditions: squamous cell lung cancer; large cell lung cancer; stage IIIB non-small cell lung cancer; adenocarcinoma of the lung
66. Recruiting Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
67. Not yet recruiting Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the larynx; ...
68. Recruiting Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer
69. Recruiting Combination Chemotherapy and Filgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Conditions: recurrent uterine sarcoma; uterine leiomyosarcoma
70. Recruiting Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer 2
Conditions: stage II breast cancer; stage IIIA breast cancer
71. Recruiting Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
72. Recruiting Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; squamous cell lung cancer; large cell lung cancer; adenocarcinoma of the lung; ...
73. Not yet recruiting Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage III prostate cancer
74. Recruiting Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer
Conditions: Male Breast Cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IV breast cancer
75. Recruiting Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
Condition: Prostate Cancer
76. Recruiting Combination Chemotherapy in Treating Women With Resected Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer
77. Recruiting Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
78. Recruiting Combination Chemotherapy in Treating Women With Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
79. Recruiting Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
Conditions: adenocarcinoma of the pancreas; stage IVB pancreatic cancer
80. Recruiting Combination Chemotherapy Plus Radiation Therapy With or Without Gefitinib in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Conditions: squamous cell lung cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
81. Recruiting Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
82. Recruiting Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
Conditions: stage II gastric cancer; stage III gastric cancer
83. Recruiting Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Conditions: stage IV breast cancer; recurrent breast cancer; stage IV gastric cancer; recurrent gastric cancer; metastatic osteosarcoma; ...
84. Recruiting This study is to assess the efficacy and safety of ZD6474 in subjects with Non-small cell lung cancer.
Conditions: Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm
85. Recruiting Combination Chemotherapy Compared With Observation in Treating Women With Relapsed Nonmetastatic Breast Cancer
Conditions: recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
86. Recruiting Chemotherapy With or Without Radiation Therapy Before Surgery in Treating Patients With Non-Small Cell Lung Cancer
Conditions: squamous cell lung cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; adenosquamous cell lung cancer
87. Recruiting Combination Chemotherapy Followed by Radiation Therapy With or Without Surgery in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; inflammatory breast cancer
88. Recruiting Combination Chemotherapy in Treating Patients With Relapsed Small Cell Lung Cancer
Condition: Recurrent Small Cell Lung Cancer
89. Recruiting Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
Conditions: squamous cell lung cancer; large cell lung cancer; stage IIIB non-small cell lung cancer; adenosquamous cell lung cancer
90. Recruiting Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors
Condition: Neoplasms
91. Recruiting Docetaxel and Gemcitabine with Filgrastim-SD/01 Support in Patients with Advanced Non-Small Cell Lung Carcinoma
Condition: Non-small cell lung cancer
92. Recruiting Trastuzumab Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
93. Recruiting Evaluation of Differing Taxanes/Taxane Combinations on the Outcomes of Patients with Operable Breast Cancer
Condition: Breast Cancer
94. Recruiting Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
Condition: Neutropenia
95. Suspended Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer
Condition: Prostatic Neoplasms
96. Recruiting Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
97. Recruiting Chemotherapy With or Without Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
Conditions: recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the oropharynx; ...
98. Recruiting Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
99. Recruiting Bevacizumab to Treat Inflammatory Breast Cancer
Condition: Breast Cancer
100. Recruiting Phase I Trial of ABT-751 in Children with Solid Tumors
Condition: Neoplasms
101. Recruiting Evaluation of Bay 59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients
Conditions: Breast Neoplasms; Metastases, Neoplasm

No. 1 - 50 Clkinical Trials / 51 - 101 Clinical trials /

 

 


Site map:

21cecPharm Home / All about Paclitaxel / All about Docetaxel / How to Order Pharmaceuticals /  Contact us

21CEC Home  / PharmaceuticalsOrder form / GoldArt GoldPhoto / Gold Christmas Cards /GoldArt Jewelry / Order  / Contact us /

21CEP Home / Drugs Suppliers World Invest World TradeWorld Partners / World Travel / Message Board / Services    /   Contact Us /
E-Commerce Newsletter   /  21st Century Magazine      / 21st Century Cinema

 

Copyright (C) 1996 - 2003 by 21CEP 21ceps.jpg (3499 bytes)